Drug
VX 993
VX 993: highest development phase Phase 2, developed by Vertex Pharmaceuticals. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-993 NCT06619860 | Phase 2 | Diabetic Peripheral Neuropathic Pain |
| VX-993 NCT06508762 | Phase 1 | Pain |
| VX-993 NCT05653323 | Phase 1 | Pain |
Latest
No recent events.
Follow VX 993 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.